Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18244
Country/Region: Malawi
Year: 2018
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $6,476,430 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $64,732
Care: TB/HIV (HVTB) $25,161
Care: Pediatric Care and Support (PDCS) $99,484
Sexual Prevention: Abstinence/Be Faithful (HVAB) $425,000
Testing: HIV Testing and Counseling (HVCT) $948,137
Sexual Prevention: Other Sexual Prevention (HVOP) $75,000
Treatment: Adult Treatment (HTXS) $4,328,331
Treatment: Pediatric Treatment (PDTX) $510,585
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 112,824
HTS_SELF 15-19, Female, Directly-Assisted 2019 9,070
HTS_SELF 15-19, Female, Unassisted 2019 1,590
HTS_SELF 15-19, Male, Directly-Assisted 2019 7,417
HTS_SELF 15-19, Male, Unassisted 2019 2,952
HTS_SELF 20-24, Female, Directly-Assisted 2019 11,504
HTS_SELF 20-24, Female, Unassisted 2019 1,995
HTS_SELF 20-24, Male, Directly-Assisted 2019 9,188
HTS_SELF 20-24, Male, Unassisted 2019 3,705
HTS_SELF 25-29, Female, Directly-Assisted 2019 2,301
HTS_SELF 25-29, Female, Unassisted 2019 1,995
HTS_SELF 25-29, Male, Directly-Assisted 2019 18,391
HTS_SELF 25-29, Male, Unassisted 2019 3,705
HTS_SELF 30-34, Female, Directly-Assisted 2019 1,013
HTS_SELF 30-34, Female, Unassisted 2019 983
HTS_SELF 30-34, Male, Directly-Assisted 2019 9,179
HTS_SELF 30-34, Male, Unassisted 2019 1,825
HTS_SELF 35-39, Female, Directly-Assisted 2019 1,013
HTS_SELF 35-39, Female, Unassisted 2019 983
HTS_SELF 35-39, Male, Directly-Assisted 2019 9,179
HTS_SELF 35-39, Male, Unassisted 2019 1,825
HTS_SELF 40-49, Female, Directly-Assisted 2019 640
HTS_SELF 40-49, Female, Unassisted 2019 585
HTS_SELF 40-49, Male, Directly-Assisted 2019 5,422
HTS_SELF 40-49, Male, Unassisted 2019 1,086
HTS_SELF 50+, Female, Directly-Assisted 2019 413
HTS_SELF 50+, Female, Unassisted 2019 399
HTS_SELF 50+, Male, Directly-Assisted 2019 3,727
HTS_SELF 50+, Male, Unassisted 2019 741
HTS_SELF Directly-Assisted 2019 88,456
HTS_SELF Unassisted 2019 24,368
HTS_TST 15-19, Female, Negative 2019 2
HTS_TST 15-19, Male, Negative 2019 14
HTS_TST 20-24, Female, Negative 2019 2
HTS_TST 20-24, Male, Negative 2019 14
HTS_TST 25-29, Female, Negative 2019 113
HTS_TST 25-29, Female, Negative 2019 17
HTS_TST 25-29, Female, Negative 2019 299
HTS_TST 25-29, Female, Negative 2019 104
HTS_TST 25-29, Female, Negative 2019 243
HTS_TST 25-29, Female, Negative 2019 4
HTS_TST 25-29, Female, Negative 2019 2
HTS_TST 25-29, Female, Negative 2019 3
HTS_TST 25-29, Female, Negative 2019 1,328
HTS_TST 25-29, Female, Negative 2019 946
HTS_TST 25-29, Male, Negative 2019 1,350
HTS_TST 25-29, Male, Negative 2019 27
HTS_TST 25-29, Male, Negative 2019 1,114
HTS_TST 25-29, Male, Negative 2019 275
HTS_TST 25-29, Male, Negative 2019 865
HTS_TST 25-29, Male, Negative 2019 150
HTS_TST 25-29, Male, Negative 2019 5
HTS_TST 25-29, Male, Negative 2019 1
HTS_TST 25-29, Male, Negative 2019 1,328
HTS_TST 25-29, Male, Negative 2019 1,669
HTS_TST 30-34, Female, Negative 2019 102
HTS_TST 30-34, Female, Negative 2019 16
HTS_TST 30-34, Female, Negative 2019 270
HTS_TST 30-34, Female, Negative 2019 95
HTS_TST 30-34, Female, Negative 2019 219
HTS_TST 30-34, Female, Negative 2019 4
HTS_TST 30-34, Female, Negative 2019 2
HTS_TST 30-34, Female, Negative 2019 2
HTS_TST 30-34, Female, Negative 2019 1,196
HTS_TST 30-34, Female, Negative 2019 377
HTS_TST 30-34, Male, Negative 2019 1,154
HTS_TST 30-34, Male, Negative 2019 23
HTS_TST 30-34, Male, Negative 2019 953
HTS_TST 30-34, Male, Negative 2019 235
HTS_TST 30-34, Male, Negative 2019 739
HTS_TST 30-34, Male, Negative 2019 128
HTS_TST 30-34, Male, Negative 2019 4
HTS_TST 30-34, Male, Negative 2019 1
HTS_TST 30-34, Male, Negative 2019 1,136
HTS_TST 30-34, Male, Negative 2019 821
HTS_TST 35-39, Female, Negative 2019 74
HTS_TST 35-39, Female, Negative 2019 11
HTS_TST 35-39, Female, Negative 2019 196
HTS_TST 35-39, Female, Negative 2019 68
HTS_TST 35-39, Female, Negative 2019 159
HTS_TST 35-39, Female, Negative 2019 3
HTS_TST 35-39, Female, Negative 2019 1
HTS_TST 35-39, Female, Negative 2019 2
HTS_TST 35-39, Female, Negative 2019 869
HTS_TST 35-39, Female, Negative 2019 252
HTS_TST 35-39, Male, Negative 2019 988
HTS_TST 35-39, Male, Negative 2019 20
HTS_TST 35-39, Male, Negative 2019 815
HTS_TST 35-39, Male, Negative 2019 201
HTS_TST 35-39, Male, Negative 2019 633
HTS_TST 35-39, Male, Negative 2019 109
HTS_TST 35-39, Male, Negative 2019 4
HTS_TST 35-39, Male, Negative 2019 1
HTS_TST 35-39, Male, Negative 2019 972
HTS_TST 35-39, Male, Negative 2019 760
HTS_TST 40-49, Female, Negative 2019 42
HTS_TST 40-49, Female, Negative 2019 6
HTS_TST 40-49, Female, Negative 2019 110
HTS_TST 40-49, Female, Negative 2019 38
HTS_TST 40-49, Female, Negative 2019 91
HTS_TST 40-49, Female, Negative 2019 1
HTS_TST 40-49, Female, Negative 2019 1
HTS_TST 40-49, Female, Negative 2019 2
HTS_TST 40-49, Female, Negative 2019 488
HTS_TST 40-49, Female, Negative 2019 46
HTS_TST 40-49, Male, Negative 2019 1,273
HTS_TST 40-49, Male, Negative 2019 25
HTS_TST 40-49, Male, Negative 2019 1,051
HTS_TST 40-49, Male, Negative 2019 260
HTS_TST 40-49, Male, Negative 2019 815
HTS_TST 40-49, Male, Negative 2019 141
HTS_TST 40-49, Male, Negative 2019 5
HTS_TST 40-49, Male, Negative 2019 1
HTS_TST 40-49, Male, Negative 2019 1,253
HTS_TST 40-49, Male, Negative 2019 811
HTS_TST 50+, Male, Negative 2019 1
HTS_TST By Key Population: FSW, Negative 2019 244
HTS_TST By Key Population: MSM, Negative 2019 113
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 91,024
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2019 6
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 47
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 10
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 10
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 156
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 1,211
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 156
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1,211
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 3
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 51
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 86
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 5,516
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 86
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 5,516
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 207
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 20
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 1,306
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 20
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 1,306
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 28
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 314
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 2,097
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 517
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 2,382
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 41
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 192
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 31
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 256
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 56
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 54
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 618
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 835
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 618
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 835
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 4
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 252
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 41
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 100
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 41
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 100
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 7
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 3,455
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 749
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 732
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 517
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 1,436
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 517
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,436
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 161
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 767
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 4
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 348
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 2,664
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 580
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 559
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 2,492
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 5,094
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 2,492
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 5,094
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 44
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 246
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 452
HTS_TST_POS 15-19, Female, Positive 2019 1
HTS_TST_POS 15-19, Male, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 1
HTS_TST_POS 20-24, Male, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 37
HTS_TST_POS 25-29, Female, Positive 2019 16
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 7
HTS_TST_POS 25-29, Female, Positive 2019 146
HTS_TST_POS 25-29, Male, Positive 2019 31
HTS_TST_POS 25-29, Male, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 63
HTS_TST_POS 25-29, Male, Positive 2019 22
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 11
HTS_TST_POS 25-29, Male, Positive 2019 163
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 45
HTS_TST_POS 30-34, Female, Positive 2019 20
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 9
HTS_TST_POS 30-34, Female, Positive 2019 214
HTS_TST_POS 30-34, Male, Positive 2019 49
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 30-34, Male, Positive 2019 149
HTS_TST_POS 30-34, Male, Positive 2019 51
HTS_TST_POS 30-34, Male, Positive 2019 9
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 27
HTS_TST_POS 30-34, Male, Positive 2019 279
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 42
HTS_TST_POS 35-39, Female, Positive 2019 18
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 8
HTS_TST_POS 35-39, Female, Positive 2019 16
HTS_TST_POS 35-39, Male, Positive 2019 46
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 35-39, Male, Positive 2019 158
HTS_TST_POS 35-39, Male, Positive 2019 54
HTS_TST_POS 35-39, Male, Positive 2019 9
HTS_TST_POS 35-39, Male, Positive 2019 6
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 29
HTS_TST_POS 35-39, Male, Positive 2019 228
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 55
HTS_TST_POS 40-49, Female, Positive 2019 24
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 12
HTS_TST_POS 40-49, Female, Positive 2019 11
HTS_TST_POS 40-49, Male, Positive 2019 74
HTS_TST_POS 40-49, Male, Positive 2019 8
HTS_TST_POS 40-49, Male, Positive 2019 301
HTS_TST_POS 40-49, Male, Positive 2019 103
HTS_TST_POS 40-49, Male, Positive 2019 40
HTS_TST_POS 40-49, Male, Positive 2019 12
HTS_TST_POS 40-49, Male, Positive 2019 2
HTS_TST_POS 40-49, Male, Positive 2019 54
HTS_TST_POS 40-49, Male, Positive 2019 422
HTS_TST_POS By Key Population: FSW, Positive 2019 88
HTS_TST_POS By Key Population: MSM, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: <1, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 162
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 162
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 122
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 122
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 35
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 112
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 81
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 139
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 49
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 58
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 78
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 41
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 83
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 6
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,500
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 223
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 36
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 1,759
PP_PREV 25-29, Female 2019 1,519
PP_PREV 25-29, Male 2019 1,839
PP_PREV 30-34, Female 2019 3,693
PP_PREV 30-34, Male 2019 1,905
PP_PREV 35-39, Female 2019 4,281
PP_PREV 35-39, Male 2019 1,670
PP_PREV 40-49, Female 2019 977
PP_PREV 40-49, Male 2019 4,512
PP_PREV Age/sex: 15-19 Female 2019 385
PP_PREV Age/sex: 15-19 Male 2019 154
PP_PREV Age/sex: 20-24 Female 2019 847
PP_PREV Age/sex: 20-24 Male 2019 385
PP_PREV Age/sex: 50+ Female 2019 304
PP_PREV Age/sex: 50+ Male 2019 227
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 22,698
PP_PREV Sum of Age/Sex disaggregates 2019 2,302
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 21
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 148
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 21
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 230
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 420
TB_PREV By Age/Sex (Numerator): <15, Female 2019 293
TB_PREV By Age/Sex (Numerator): <15, Male 2019 293
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 2,057
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 3,233
TB_PREV IPT, Life-long ART, Already, Positive 2019 588
TB_PREV IPT, Life-long ART, New, Positive 2019 5,288
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 5,876
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 6,531
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 327
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 327
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 2,285
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 3,592
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 654
TB_PREV_den IPT, Life-long ART, New, Positive 2019 5,877
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 42
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 296
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 42
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 465
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 845
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 873
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 43
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 306
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 43
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 481
TX_CURR 25-29, Female, Positive 2019 1,009
TX_CURR 25-29, Male, Positive 2019 246
TX_CURR 30-34, Female, Positive 2019 1,574
TX_CURR 30-34, Male, Positive 2019 558
TX_CURR 35-39, Female, Positive 2019 1,770
TX_CURR 35-39, Male, Positive 2019 924
TX_CURR 40-49, Female, Positive 2019 2,234
TX_CURR 40-49, Male, Positive 2019 1,831
TX_CURR Age/Sex: <1 2019 15
TX_CURR Age/Sex: <1-9 2019 135
TX_CURR Age/Sex: 10-14 Female 2019 90
TX_CURR Age/Sex: 10-14 Male 2019 78
TX_CURR Age/Sex: 15-19 Female 2019 232
TX_CURR Age/Sex: 15-19 Male 2019 245
TX_CURR Age/Sex: 20-24 Female 2019 581
TX_CURR Age/Sex: 20-24 Male 2019 217
TX_CURR Age/Sex: 50+ Female 2019 1,158
TX_CURR Age/Sex: 50+ Male 2019 1,257
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 14,154
TX_CURR Sum of age/sex disaggregates 2019 477
TX_NEW 25-29, Female, Positive 2019 74
TX_NEW 25-29, Male, Positive 2019 99
TX_NEW 30-34, Female, Positive 2019 89
TX_NEW 30-34, Male, Positive 2019 234
TX_NEW 35-39, Female, Positive 2019 84
TX_NEW 35-39, Male, Positive 2019 246
TX_NEW 40-49, Female, Positive 2019 107
TX_NEW 40-49, Male, Positive 2019 463
TX_NEW Breastfeeding status 2019 242
TX_NEW By Age/Sex: <1 2019 17
TX_NEW By Age/Sex: 1-9 2019 41
TX_NEW By Age/Sex: 10-14 Female 2019 5
TX_NEW By Age/Sex: 10-14 Male 2019 6
TX_NEW By Age/Sex: 15-19 Female 2019 138
TX_NEW By Age/Sex: 15-19 Male 2019 193
TX_NEW By Age/Sex: 20-24 Female 2019 180
TX_NEW By Age/Sex: 20-24 Male 2019 194
TX_NEW By Age/Sex: 50+ Female 2019 3
TX_NEW By Age/Sex: 50+ Male 2019 55
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 2,228
TX_NEW Pregnancy status 2019 917
TX_NEW Sum of Age/Sex disaggregates 2019 774
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 6,323
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 220
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 32
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 213
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 32
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 3,564
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 63
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 2,136
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 63
TX_PVLS_den Denominator: Indication: Routine 2019 6,133
TX_PVLS_den Denominator: Indication: Targeted 2019 190
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 65
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 64
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 630
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,419
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 2,178
TX_RET Numerator by Status: Breastfeeding 2019 6
TX_RET Numerator by Status: Pregnant 2019 9
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 2,195
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 66
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 65
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 635
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,429
TX_RET_den Denominator by Status: Breastfeeding 2019 6
TX_RET_den Denominator by Status: Pregnant 2019 9
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 9,630
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 455
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 745
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 2,909
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 5,521
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 4,333
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 5,295
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 9,628
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 6,655
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 74
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 2,870
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 31
Cross Cutting Budget Categories and Known Amounts Total: $1,495,128
Key Populations: Sex Workers $41,112
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Key Populations: MSM and TG $232,970
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Human Resources for Health $471,046
Adolescent Girls and Young Women (AGYW) $750,000